Syncom Formulations Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was INR 1,236.75 million compared to INR 1,058.92... Syncom Formulations (India) Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was INR 1,236.75 million compared to INR 1,058.92 million a year ago. Revenue was INR 1,295.47 million compared to INR 1,117.43 million a year ago. Net income was INR 109.08 million compared to INR 74.59 million a year ago. Basic earnings per share from continuing operations was INR 0.15 compared to INR 0.09 a year ago. Diluted earnings per share from continuing operations was INR 0.15 compared to INR 0.09 a year ago. Basic earnings per share was INR 0.15 compared to INR 0.09 a year ago. Diluted earnings per share was INR 0.15 compared to INR 0.09 a year ago.
